Mengbi Guo
Key Laboratory Of Structure Based Drugs Design And Discovery
Shenyang, 110016, China
Shenyang, 110016, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Discovery of Subnanomolar and Highly Selective Carbonic Anhydrase II Inhibitors Featuring L-Shaped Scaffolds via Active-Site-Matched Fragment Growing.
Journal: Journal of medicinal chemistry
Published: June 15, 2026
Discovery of anti-glaucoma agents with dual hCA II inhibitory and nitric oxide-releasing activity and their neuroprotective effects.
Journal: European journal of medicinal chemistry
Published: February 13, 2026
Discovery of Novel NO-Donor Containing hCA II Inhibitors with Retinal Ganglion Cell-Protective Effects for the Efficient Treatment of Glaucoma.
Journal: Journal of medicinal chemistry
Published: December 18, 2025
Discovery of Novel α,β-Unsaturated Amide Derivatives as Candidate Antifungals to Overcome Fungal Resistance.
Journal: Journal of medicinal chemistry
Published: July 30, 2024
Developing Novel Coumarin-Containing Azoles Antifungal Agents by the Scaffold Merging Strategy for Treating Azole-Resistant Candidiasis.
Journal: Journal of medicinal chemistry
Published: September 19, 2023
Discovery of novel artemisinin-sulfonamidehybrids as potential carbonicanhydraseIX inhibitors with improved antiproliferative activities.
Journal: Bioorganic chemistry
Published: August 11, 2020
Design, Synthesis and Antifungal Activity of Novel Benzofuran-Triazole Hybrids.
Journal: Molecules (Basel, Switzerland)
Published: April 20, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026